ACCOUNTS - Final Accounts

ARROW MEDICAL PRODUCTS LIMITED - Company Information

Caseware UK (AP4) 2022.0.179 2022.0.179 2023-06-300500790502023-06-30Its principal activity is to seek new customers for assembly and distribution services of medical devices, garments or textile products however, the company has not traded within the periodForefront Medical Investment Pte2022-07-01true0truetrue 05007905 2022-07-01 2023-06-30 05007905 2021-07-01 2022-06-30 05007905 2023-06-30 05007905 2022-06-30 05007905 c:Director4 2022-07-01 2023-06-30 05007905 d:Non-currentFinancialInstruments 2023-06-30 05007905 d:Non-currentFinancialInstruments 2022-06-30 05007905 d:Non-currentFinancialInstruments d:AfterOneYear 2023-06-30 05007905 d:Non-currentFinancialInstruments d:AfterOneYear 2022-06-30 05007905 d:ShareCapital 2023-06-30 05007905 d:ShareCapital 2022-06-30 05007905 d:RetainedEarningsAccumulatedLosses 2023-06-30 05007905 d:RetainedEarningsAccumulatedLosses 2022-06-30 05007905 c:EntityHasNeverTraded 2022-07-01 2023-06-30 05007905 c:FRS102 2022-07-01 2023-06-30 05007905 c:AuditExempt-NoAccountantsReport 2022-07-01 2023-06-30 05007905 c:FullAccounts 2022-07-01 2023-06-30 05007905 c:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 iso4217:GBP xbrli:pure

Arrow Medical Products Limited

Registered number: 05007905

Information for filing with the Registrar

For the year ended 30 June 2023


ARROW MEDICAL PRODUCTS LIMITED REGISTERED NUMBER:05007905

BALANCE SHEET

AS AT 30 JUNE 2023

		2023		2022
Note		£		£


Current assets
Cash at bank and in hand		4		4
		4		4
Total assets less current liabilities			4		4
Creditors: amounts falling due after more than one year	3		(605,390)		(605,390)

Net liabilities			(605,386)		(605,386)

Capital and reserves
Called up share capital	1	1
Profit and loss account	(605,387)	(605,387)
	(605,386)	(605,386)

- 1 -


ARROW MEDICAL PRODUCTS LIMITED REGISTERED NUMBER:05007905

BALANCE SHEET (CONTINUED)

AS AT 30 JUNE 2023

For the year ended 30 June 2023 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

R J Hayman

Director

Date: 14 February 2024

The notes on pages 3 to 4 form part of these financial statements.

- 2 -


ARROW MEDICAL PRODUCTS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2023

1.	General information

Arrow Medical Products Limited (no. 05007905) is a company limited by shares incorporated in England and Wales. Its registered office is Hatton Garden Industrial Estate, Kington, Herefordshire, HR5 3RB.
Its principal activity is to seek new customers for assembly and distribution services of medical devices, garments or textile products however, the company has not traded within the period.
The financial statements have been presented in Pound Sterling as this is currency of the primary economic environment in which the Company operates and is rounded to the nearest pound.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

2.2

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

2.3

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

3.	Creditors: Amounts falling due after more than one year
		2023	2022
		£	£

Amounts owed to group undertakings	605,390	605,390
	605,390	605,390

4.	Related party transactions
	The Company is a wholly owned subsidiary of Arrow Medical Limited and has taking advantage of the exemption in FRS102 section 33 not exemption not to disclose transactions with other members of the group.

- 3 -


ARROW MEDICAL PRODUCTS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2023

5.	Ultimate parent company and controlling party

The immediate parent company is Arrow Medical Limited. The immediate parent company of Arrow Medical Limited is Forefront Medical Investment Pte. Ltd, Its registered office is 35 Joo Koon Circle, 629110, Singapore.
The ultimate parent company is Vicplas International Ltd a company incorporated in Singapore and listed on the mainboard of the Singapore Exchange Securities Trading Limited.
The directors have confirmed that there is no overall controlling party due to listing of the ultimate parent company.

- 4 -